NYSEArca - Delayed Quote USD

Innovator IBD Breakout Opportunities ETF (BOUT)

40.14
+0.98
+(2.49%)
At close: November 21 at 4:00 PM EST

Performance Overview: BOUT

Trailing returns as of 11/20/2024. Category is Mid-Cap Growth.

YTD Return

BOUT
18.43%
Category
12.67%

1-Year Return

BOUT
29.36%
Category
34.27%

3-Year Return

BOUT
1.91%
Category
2.17%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
BOUT
Category
YTD
10.44%
12.67%
1-Month
-0.14%
-0.15%
3-Month
1.23%
3.97%
1-Year
27.45%
34.27%
3-Year
0.91%
-2.17%
5-Year
14.06%
10.20%
10-Year
0.00%
9.99%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
BOUT
Category
2023
13.27%
21.37%
2022
-22.61%
-27.79%
2021
22.69%
13.05%
2020
50.56%
39.26%
2019
20.59%
32.52%

ETF Summary

The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

ETF Overview

Category Mid-Cap Growth
Fund Family Innovator ETFs
Net Assets 12.79M
YTD Daily Total Return 18.43%
Yield 1.21%
Legal Type Exchange Traded Fund

Related Tickers